Related Experiment Video
Updated: Oct 7, 2025

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.3K
Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study
A Dal-Bianco1, R Schranzer1,2, G Grabner1,2
1Department of Neurology, Vienna, Austria.
Frontiers in Neurology
|January 7, 2022
Summary
Iron rim lesions in multiple sclerosis patients are linked to more brain lesions, greater thalamic atrophy, and elevated serum neurofilament light chain levels, indicating neurodegeneration. These findings highlight the destructive nature of iron rim lesions in MS progression.
Area of Science:
- Neuroscience
- Radiology
- Biomarkers
Background:
- Multiple sclerosis (MS) is a central nervous system disease causing demyelination and neurodegeneration, leading to physical and neuropsychological deficits.
- Iron rim lesions (IRLs) in MS are associated with severe tissue destruction and clinical disability accumulation.
- Understanding the role of IRLs and associated biomarkers is crucial for tracking MS progression.
Purpose of the Study:
- To assess subcortical atrophy and ventricular enlargement using 7 Tesla (T) MRI in MS patients with and without IRLs.
- To evaluate serum neurofilament light chain (sNfL) levels as a biomarker for neurodegeneration in MS patients with IRLs.
- To correlate imaging and biomarker data with neuropsychological performance in MS patients with and without IRLs.
Main Methods:
- Utilized 7-T MRI (SWI, FLAIR, MP2RAGE) and 3D Segmentation Software for volumetric analysis of lesions, subcortical structures, and ventricles in 29 MS patients.
- Measured serum neurofilament light chain (sNfL) concentrations using the Simoa SR-X Analyzer.
- Conducted neurological and neuropsychological examinations, including the Symbol Digit Modalities Test (SDMT), to assess clinical and cognitive status.
Main Results:
- Patients with IRLs had higher FLAIR lesion counts and greater MP2Rage lesion volume.
- IRL patients exhibited smaller thalamic volumes and enlarged lateral ventricles over 3 years.
- Higher sNfL concentrations were observed in IRL patients and correlated with poorer SDMT performance, irrespective of IRL presence.
Conclusions:
- IRL patients demonstrate increased lesion burden, thalamic atrophy, and elevated sNfL levels compared to non-IRL patients.
- The combination of IRL imaging and sNfL biomarkers may indicate neurodegenerative processes in MS.
- Preliminary findings support the destructive nature of IRLs in MS pathogenesis and progression.

